Resiquimod
Chemical Name: 1-[4-Amino-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol
Purity: ≥98%
Biological Activity
Resiquimod is a toll-like receptor 7 (TLR7) agonist. Induces upregulation of IL-6, IL-12, IFN-γ and iNOS expression in mouse bone marrow-derived macrophages (BMMs). Inhibits RANKL-induced osteoclast differentiation in mouse BMMs and human peripheral blood monocytes. Also promotes the differentiation of MDSCs into macrophages and dendritic cells. Proinflammatory and antiviral.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation.
Martins K, Steffens J, van Tongeren S, Wells J, Bergeron A, Dickson S, Dye J, Salazar A, Bavari S
PLoS ONE, 2014;9(2):e89735. -
Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor Immunity.
Derouazi M, Di Berardino-Besson W, Belnoue E, Hoepner S, Walther R, Benkhoucha M, Teta P, Dufour Y, Yacoub Maroun C, Salazar A, Martinvalet D, Dietrich P, Walker P
Cancer Res, 2015;75(15):3020-31. -
Resiquimod, a TLR7/8 agonist, promotes differentiation of myeloid-derived suppressor cells into macrophages and dendritic cells.
Lee et al.
Arch.Pharm.Res., 2014;37:1234 -
Imiquimod and resiquimod as novel immunomodulators.
Dockrell and Kinghorn
J.Antimicrob.Chemother., 2001;48:751 -
R848, a toll-like receptor 7 agonist, inhibits osteoclast differentiation but not survival or bone-resorbing function of mature osteoclasts.
Miyamoto et al.
Cytotechnology., 2012;64:331 -
Modulation of TH1 and Th2 cytokine production with the immune response modifiers, R-848 and imiq.
Wagner et al.
Cell Immunol., 1999;191:10
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citations for Resiquimod
The citations listed below are publications that use Tocris products. Selected citations for Resiquimod include:
2 Citations: Showing 1 - 2
-
Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine.
Authors: Ming Et al.
Cell Discov 2022;8:10
-
Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor Antibodies.
Authors: Yumi Et al.
Front Oncol 2022;12:869078
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for Resiquimod
There are currently no reviews for this product. Be the first to review Resiquimod and earn rewards!
Have you used Resiquimod?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image